Literature DB >> 3998504

Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE).

P M Dowd, A Kobza Black, P M Woollard, R D Camp, M W Greaves.   

Abstract

The responses to 12-HETE in normal human skin have been investigated by means of intradermal and topical administration in 15 subjects. Intradermal infusion of 12-HETE produced a neutrophil polymorphonuclear and mononuclear infiltrate in the dermis. Topical administration resulted in a dose-related erythematous response to 200 ng-50 micrograms. This was accompanied by a neutrophil and mononuclear dermal infiltrate at 6 and 24 h after application. In addition, collections of neutrophils were present in the epidermis in 4 of 10 subjects biopsied at 6 h and in all patients biopsied 24 h after topical application. Intradermal and topical application of 9-hydroxyoctadecadienoic acid (9-HODD), a chemically similar but chemokinetically inactive substance, did not produce neutrophil infiltration of the epidermis, nor did the chemical irritant nonanoic acid. The results suggest that the cellular infiltrates produced in vivo in humans by 12-HETE are due to its chemoattractant properties and are not the result of a nonspecific inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3998504     DOI: 10.1111/1523-1747.ep12273537

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  17 in total

1.  Cutaneous responses to 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and 5,12-dihydroxyeicosatetraenoic acid (leukotriene B4) in psoriasis and normal human skin.

Authors:  P M Dowd; A K Black; P W Woollard; M W Greaves
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  Proceedings of the British Pharmacological Society. Oxford, 9th-11th September 1987. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

3.  Alterations in Epidermal Eicosanoid Metabolism Contribute to Inflammation and Impaired Late Differentiation in FLG-Mutated Atopic Dermatitis.

Authors:  Stefan Blunder; Ralph Rühl; Verena Moosbrugger-Martinz; Christine Krimmel; Anita Geisler; Huiting Zhu; Debra Crumrine; Peter M Elias; Robert Gruber; Matthias Schmuth; Sandrine Dubrac
Journal:  J Invest Dermatol       Date:  2016-10-26       Impact factor: 8.551

4.  Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.

Authors:  E Wong; R M Barr; F M Cunningham; K Mistry; P M Woollard; A I Mallet; M W Greaves
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

5.  Studies on the mechanism of omega-hydroxylation of platelet 12-hydroxyeicosatetraenoic acid (12-HETE) by unstimulated neutrophils.

Authors:  A J Marcus; L B Safier; H L Ullman; N Islam; M J Broekman; C von Schacky
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

6.  Effect of dithranol treatment on arachidonic acid and its lipoxygenase products in psoriasis.

Authors:  R M Barr; E Wong; F M Cunningham; A I Mallet; M W Greaves
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

7.  Interleukin-8 stimulates the formation of 15-hydroxy-eicosatetraenoic acid by human neutrophils in vitro.

Authors:  K Fogh; C G Larsen; L Iversen; K Kragballe
Journal:  Agents Actions       Date:  1992-03

8.  Monohydroxy fatty acids esterified to phospholipids are decreased in lesional psoriatic skin.

Authors:  B Grøn; L Iversen; V Ziboh; K Kragballe
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

9.  Dithranol-induced down-regulation of 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] receptors in a human epidermal cell line.

Authors:  L Kemény; E Gross; P Arenberger; T Ruzicka
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

10.  The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases.

Authors:  Lesley E Rhodes; Karl Gledhill; Mojgan Masoodi; Ann K Haylett; Margaret Brownrigg; Anthony J Thody; Desmond J Tobin; Anna Nicolaou
Journal:  FASEB J       Date:  2009-07-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.